Posts in category: Uncategorized

UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.

The number of injuries in youth athletics is significantly reduced when coaches and parents have access to digital information on adolescent growth. It also takes twice as long for the first injury to occur. This is shown in a study from Linköping University published in the British Journal of Sports Medicine.

COVID-19, caused by an infection with the SARS-CoV-2 virus, was declared a global pandemic by the World Health Organization (WHO) in March 2020. While some people developed severe illness and required medical care, many people reported only mild-to-moderate symptoms, if any at all.

Sarcopenia is a degenerative disease characterized by a pathological decrease in muscle strength that particularly affects older people. Researchers at the University of Barcelona have developed a new tool to assess the presence and severity of this muscular deterioration.

A population data linkage study using anonymized primary and secondary care health records in Swansea University’s SAIL Databank has revealed that in 2020 and 2021, fewer people in Wales were being diagnosed with long-term conditions than expected.

Yersinia bacteria cause a variety of human and animal diseases, the most notorious being the plague, caused by Yersinia pestis. A relative, Yersinia pseudotuberculosis, causes gastrointestinal illness and is less deadly, but naturally infects both mice and humans, making it a useful model for studying its interactions with the immune system.

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited efficacy against glioblastoma—the deadliest type of primary brain cancer—and other solid tumors.

A new study published in Science Immunology points to a promising therapeutic approach for future cancer treatments based on natural killer cells (NK), which are immune cells that bind to tumor cells and destroy them.

Many autistic people rely on important healthcare coverage from Medicaid for continued services and supports throughout their life. But when entering adulthood, autistic adolescents are facing increased risk of disenrollment from the Medicaid program if they live in a state without a Medicaid waiver. Recently published in JAMA Network Open, researchers from the A.J. Drexel Autism Institute at Drexel University examined whether state-level waivers were associated with reduced risk of Medicaid disenrollment among autistic transition-age youth.

A new review paper titled “Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells” has been published in Oncotarget.